Latest News

  • 2024 ​Cajun Crawfish Boil
    Saturday, April 27th, 2024, Tyler’s Hope for a Dystonia Cure held their 5th Annual Cajun Crawfish Boil at Momentum Labs in Alachua. There was something for […]
  • Cerebellar dysfunction in rodent models with dystonia, tremor, and ataxia
    Meike E. van der Heijden1,2* and Roy V. Sillitoe1,2,3,4,5* Dystonia is a movement disorder characterized by involuntary co- or over-contractions of the muscles, which results in abnormal […]
  • 2022 Events
    Thanks to the support of so many sponsors and friends, 2022 has been a huge success! We spent the year raising money for vital research, spreading […]
  • Welcome to the Team!
    New Board Members
    Carl Smith Carl Smith has been involved with the foundation since its inception. Over the years he has served as a volunteer, advocate, and donated countless […]
  • Centers of Excellence
    In September the Tyler’s Hope for a Dystonia Cure Foundation announced that Duke University has received the organization’s highest honor for excellence in research, education, and […]
  • Tyler’s Hope Funded Breakthrough Discovery
    ​Using drug screening, drug testing and imaging methods, researchers reported that ritonavir corrected abnormal protein features in the brain and had therapeutic effects in a mouse […]
  • Groundbreaking Dystonia Research
    Tyler’s Hope Foundation Grants Duke University the Center ofExcellence Award for Groundbreaking Dystonia Research Gainesville, FL, September 12, 2022 – The Tyler’s Hope for a Dystonia […]
  • Electrophysiological
    Characterization of cholinergic neurons in DYT1 dystonia
    Researchers at the Tyler’s Hope Center of Excellence at the University of Florida publish work on the characterization of cholinergic neurons in DYT1 dystonia
  • Dr. Stephanie Cernera & Dr. Jun Yu
    Research Grants awarded to Advance Understanding of Dystonia
    Congratulations To Dr. Stephanie Cernera and Dr. Jun Yu. Dr. Yu was awarded an clinical fellowship and Dr. Cernera a research fellowship for, “Beyond Theta: Analyzing […]
  • Tyler’s Hope grant funds breakthrough in the fight to end DYT1 dystonia
    A new study found that an FDA-approved medication to treat HIV restored multiple brain abnormalities in a mouse model of a genetic form of dystonia.
  • Deep brain stimulation
    Long-Term Outcomes of Deep Brain Stimulation for Pediatric Dystonia
    Deep brain stimulation (DBS) has been a treatment for medication-refractory dystonia in children for over 20 years, showing short-term benefits in inherited, isolated, and idiopathic cases. A review of long-term outcomes, spanning 5 or more years post-DBS in patients under 21, reveals sustained motor improvement, with median Burke-Fahn-Marsden scores improving from 2.5% to 93.2% across dystonia subtypes. Most implants targeted the globus pallidus internus, with an average follow-up of 8.5 years. While data on neuropsychiatric outcomes and adverse events is limited, quality of life improvements persist without significant cognitive or psychiatric issues, though hardware-related complications remain a concern.
  • Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function
    Most individuals affected with DYT1 dystonia have a heterozygous 3-bp deletion in the TOR1A gene (c.907_909delGAG). The mutation appears to act through a dominant-negative mechanism compromising normal torsinA […]
  • TOR1A-gene
    TorsinB overexpression prevents abnormaltwisting in DYT1 dystonia mouse models
    In DYT1 dystonia, caused by a TOR1A mutation, torsinB levels influence disease severity. In DYT1 mouse models, lowering torsinB worsens movements and neurodegeneration, while raising it rescues these deficits, suggesting torsinB augmentation could delay symptoms.
  • VIB-Ku-LEUVEN
    Dr. Rose Goodchild’s Lab at the VIB in Belgium
    Are cellular lipids the missing link between a faulty gene and a neurological disorder? Researchers at VIB-KU Leuven have managed to get a clearer view on […]
  • Novel Therapy Development for Dystonia
    Dystonia is a movement disorder characterized by involuntary repetitive, sustained muscle contractions, or postures. About 300,000 to 500,000 individuals, including military and veteran populations, suffer from […]
  • New Imaging Technique Could Aid in Testing of New Drugs for Dystonia
    GAINESVILLE, Fla. — A new study led by University of Florida neuroscientists furthers the scientific understanding about the brain regions involved with causing dystonia, a poorly […]
  • Duke University Chapel is a chapel located at the center of the campus of Duke University in Durham, North Carolina
    Research at Duke
    Duke researchers develop new cell-based drug screening test for dystonia Published on December 8, 2016 Duke University researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, including twists and turns of different parts of the body.